Research from Redeye, Redeye AB

Redeye

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen). 

Expertise in Denmark, Finland, Norway and Sweden.

Research from Redeye

Redeye AB

Specialists in innovative and fast-growing Nordic companies within Life Science and Technology.

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen).

Equity Bottom-Up

<ul><li>Redeye expects a sequential decline against the exceptionally strong Q4, but continued double-digit YoY growth and an EBITDA margin of around 20%, reflecting ongoing supply chain improvements and the removal of the legacy product phase-out headwind, partially offset by USD/SEK weakness through mid-Q1.</li><li>Stille's Q1 report is released this Friday, April 24th.</li></ul>

Redeye expects a sequential decline against the exceptionally strong Q4, but continued double-digit YoY growth and an EBITDA margin of around 20%, reflecting ongoing supply chain improvements and the removal of the legacy product phase-out headwind, partially offset by USD/SEK weakness through mid-Q1.Stille's Q1 report is released this Friday, April 24th.

Stille (Q1 preview): Navigating headwind, expecting a solid report